News

Purespring Therapeutics Publishes Study on NPHS2 Genetic Variants Driving Adult-Onset FSGS in US and UK Populations

2 min

Viking Therapeutics VK2735 Phase 3 Obesity Trials Fully Enrolled as Company Reports Q1 2026 Results

3 min

Relay Therapeutics Q1 2026 Earnings: Zovegalisib PI3Kα Inhibitor Updates Expected May 5

2 min

Neurocrine Biosciences INGREZZA Shows Clinically Meaningful Improvement in Tardive Dyskinesia Study

2 min

Novo Nordisk's Denecimig Shows Significant Bleeding Reduction in Hemophilia A Phase 3 Trial Published in NEJM

Hemophilia A · 3 min

Addex Therapeutics GABAB PAM Shows Promise for IPF-Related Chronic Cough in Preclinical Study

2 min

IgA Nephropathy Market to Reach New Heights by 2036 as Novartis Zigakibart and Novel Immunotherapies Drive Growth

2 min

Perimeter Medical's Claire OCT+AI Receives FDA Approval for Breast Cancer Surgery Margin Assessment

2 min

Regeneron Q1 2026 Earnings: Dupixent Sales Surge 33% to $4.9B, EYLEA HD Shows Strong Growth

2 min

Sprout Pharmaceuticals Addyi (Flibanserin) Maker Named Top 10 Most Influential Health Company by TIME 2026

2 min

Clinical Outsourcing: Key Takeaways from 2026 Trends

general · 8 min

Clinical Outsourcing Trends 2026: Key Takeaways for Pharma

general · 8 min